|
| Status |
Public on Dec 11, 2019 |
| Title |
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. |
| Organism |
Mus musculus |
| Experiment type |
Expression profiling by array
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
31827283 |
| |
| Submission date |
Feb 04, 2019 |
| Last update date |
Dec 20, 2019 |
| Contact name |
Hongbo Chi |
| E-mail(s) |
hongbo.chi@stjude.org
|
| Organization name |
St Jude Children's Research Hospital
|
| Department |
Immunology
|
| Street address |
262 Danny Thomas Place
|
| City |
Memphis |
| State/province |
TN |
| ZIP/Postal code |
38105 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL21103 |
Illumina HiSeq 4000 (Mus musculus) |
| GPL23038 |
[Clariom_S_Mouse] Affymetrix Clariom S Assay, Mouse (Includes Pico Assay) |
|
| Samples (50)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE126070 |
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq] |
| GSE126071 |
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [RNA-Seq] |
| GSE137014 |
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq] |
| GSE137015 |
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq] |
| GSE137016 |
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [microarray] |
|
| Relations |
| BioProject |
PRJNA520907 |
Less...
More...